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Akkermansia muciniphila is a Gram-negative mucin-degrading bacterium that resides in the gastrointestinal tracts of humans
and animals. A. muciniphila has been linked with intestinal health and improved metabolic status in obese and type 2 diabetic
subjects. Specifically, A. muciniphila has been shown to reduce high-fat-diet-induced endotoxemia, which develops as a result of
an impaired gut barrier. Despite the accumulating evidence of the health-promoting effects of A. muciniphila, the mechanisms
of interaction of the bacterium with the host have received little attention. In this study, we used several in vitromodels to inves-
tigate the adhesion of A. muciniphila to the intestinal epithelium and its interaction with the host mucosa. We found that A.
muciniphila adheres strongly to the Caco-2 and HT-29 human colonic cell lines but not to human colonic mucus. In addition, A.
muciniphila showed binding to the extracellular matrix protein laminin but not to collagen I or IV, fibronectin, or fetuin. Im-
portantly, A. muciniphila improved enterocyte monolayer integrity, as shown by a significant increase in the transepithelial elec-
trical resistance (TER) of cocultures of Caco-2 cells with the bacterium. Further, A. muciniphila induced interleukin 8 (IL-8)
production by enterocytes at cell concentrations 100-fold higher than those for Escherichia coli, suggesting a very low level of
proinflammatory activity in the epithelium. In conclusion, our results demonstrate that A. muciniphila adheres to the intestinal
epithelium and strengthens enterocyte monolayer integrity in vitro, suggesting an ability to fortify an impaired gut barrier.
These results support earlier associative in vivo studies and provide insights into the interaction of A. muciniphila with the host.
Akkermansia muciniphila is a Gram-negative anaerobe belong-ing to the Planctomycetes-Verrucomicrobia-Chlamydiae su-
perphylum (1). A. muciniphila has been found to inhabit the gas-
trointestinal (GI) tracts of more than 90% of adult subjects
analyzed, and it constitutes 1 to 4% of the fecal microbiota (2). A.
muciniphila is capable of using intestinal mucins, the highly gly-
cosylated proteins of the epithelial mucus layer, as its sole source
of carbon and nitrogen (1). Therefore, it is not surprising that this
organism has also been detected in high numbers in mucosal bi-
opsy specimens of the human colon (3). The genome of A. muci-
niphila contains a large proportion of genes encoding secreted
proteins (567 of the 2,176 open reading frames), 61 of which have
been assigned protease, sugar hydrolase, sialidase, or sulfatase ac-
tivities, suggesting specialization in mucus utilization and adapta-
tion to the gut environment (4). There is growing evidence that A.
muciniphila is associated with gut health; e.g., fewerA.muciniphila
cells have been detected in ulcerative colitis (UC) and Crohn’s
disease (CD) patients, both in clinically active disease and during
remission, than in healthy individuals (5, 6). An inverse correla-
tion between A.muciniphila levels and the severity of acute appen-
dicitis has also been shown (7). Moreover, fecal counts of A. mu-
ciniphila cells correlate with the richness of bacterial species and
correlate inversely with type 1 diabetes, body weight, and markers
of inflammation (8–10). The effects of A. muciniphila and its me-
tabolites on mucosal gene expression patterns have been studied
using gnotobiotic mice and mouse gut organoids, respectively (11,
12). These studies showed that A. muciniphila elicits distinctive
changes in the expression of pathways involved in metabolic ho-
meostasis and immune tolerance (11, 12). In addition, A. mucini-
phila has been demonstrated to improve the metabolic profiles of
type 2 diabetic mice, to restore mucus layer thickness, and to
counteract high-fat-diet-induced lipopolysaccharide (LPS) endo-
toxemia in obese mice (13).
The ability of intestinal bacteria to adhere to the host epithe-
lium is considered important for efficient colonization and inter-
action with the host, although experimental data are scarce. In
principle, colonizing bacteria can adhere either to the protective
mucus gel covering the epithelial cell layer or directly to the en-
terocytes. In a healthy colon, the epithelial cell layer is fully cov-
ered by a thick mucus gel layer, whereas in the small intestine, the
mucus layer is thinner and discontinuous (14), allowing for direct
contacts between bacteria and host enterocytes. Despite the accu-
mulating evidence for the involvement of A. muciniphila in intes-
tinal and metabolic health, the basic mechanisms of interaction
with the host have received little attention. In this study, we inves-
tigated the adhesion of A. muciniphila to human colonic mucus,
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the Caco-2 and HT-29 intestinal epithelial cell lines, and several
extracellular matrix (ECM) proteins. In addition, we used in vitro
models to study the effects of A.muciniphila on epithelial integrity
and interleukin-8 (IL-8) release by enterocytes.
MATERIALS AND METHODS
Bacterial strains and growth conditions. A. muciniphila BAA-835T
(American Type Culture Collection) cells were grown in mucin medium
(1), and Bacteroides fragilis E-022248T ( DSM 2151  ATCC 25285)
obtained from the VTT Culture Collection (VTT Technical Research
Center of Finland, Espoo, Finland) was cultivated on Brucella agar with
hemin and vitamin K (Fluka) supplemented with 5% sheep blood. Both
strains were grown at 37°C for 2 days in an anaerobic incubator under an
atmosphere of 5% H2, 10% CO2, and 85% N2 (Concept Plus anaerobic
workstation; Ruskinn Technology Ltd.). Escherichia coli K-12-derived
TOP10 cells (Invitrogen) were grown with agitation (220 rpm) overnight
at 37°C in Luria-Bertani (LB) medium. Lactobacillus rhamnosus GG
(ATCC 53103) was cultivated overnight in static de Man-Rogosa-Sharpe
(MRS) broth (Difco) at 37°C. For the adhesion experiments, bacterial cells
were metabolically labeled by supplementing the growth medium with 10
l ml1 of [6=-3H]thymidine (14.4 Ci/mmol; PerkinElmer).
Epithelial cell lines. The Caco-2 (ACC 169) and HT-29 (ACC 299)
human colonic epithelial cell lines were purchased from the Leibniz Insti-
tute DSMZ (German Collection of Microorganisms and Cell Cultures). The
cell lines were grown at 37°C under an oxic atmosphere in an incubator
supplemented with 5% CO2. Caco-2 cells were cultivated in RPMI 1640
(Sigma) containing 20% heat-inactivated (30 min at 56°C) fetal calf serum
(FCS; Integro B.V.), 1% nonessential amino acids (Lonza), 15 mM HEPES
(Lonza), 2 mM L-glutamine (Lonza), and 100 U ml1 penicillin and strepto-
mycin (PEST; Lonza). HT-29 cells were grown in McCoy 5A medium
(Lonza) supplemented with 10% heat-inactivated FCS and with PEST.
Assessment of viability of Akkermansia muciniphila under an oxic
atmosphere. Anaerobically grown A. muciniphila cells were washed once
with phosphate-buffered saline (PBS; pH 7.4), which was kept overnight
in the anaerobic incubator to remove any oxygen from the buffer. The
bacterial cell suspension was diluted to an optical density at 600 nm
(OD600) of 0.25. The cell suspension was divided into three 96-well mi-
croplates, with 100 l well1, and the microplates were incubated for 1 h
at 37°C either in the anaerobic incubator, in an incubator with an oxic
atmosphere supplemented with 5% CO2, or under a normal oxic atmo-
sphere. Next, the cells were live-dead stained by adding 4=,6-diamidino-
2-phenylindole (DAPI) and propidium iodide (PI) at final concentrations
of 1g ml1 and 0.75g ml1, respectively, and incubating for 15 min at
room temperature, followed by one wash with PBS. The fluorescence of
the stained cell suspensions was measured with a Wallac 1420-012 multi-
label counter, using 340-nm and 460-nm (DAPI) and 545-nm and
616-nm (PI) excitation and emission filters, respectively. The stained cell
suspensions were then streaked onto microscopic slides and were ana-
lyzed by a Leica DM4000 B fluorescence microscope using filter cube A for
DAPI and filter cube N2.1 for PI.
Isolation of human intestinal mucus. Human colonic mucus was
isolated as described previously (15, 16) from healthy parts of colons from
colorectal cancer patients undergoing surgery. The use of human intesti-
nal mucus in the adhesion studies was approved by the ethical committee
of the Hospital District of Southwest Finland. All patients who donated
intestinal tissue provided written informed consent.
Preparation of a whole-cell antiserum against Akkermansia muci-
niphila. Live Akkermansia muciniphila cells were used to produce a poly-
clonal rabbit antiserum at the Laboratory Animal Centre of the University
of Helsinki. Immunization was carried out as described previously (15).
Briefly, overnight-grown cells were washed once with PBS and were re-
suspended in PBS to a final concentration of 109 ml1. This preparation
was diluted 1:1 in Freund’s complete adjuvant (first injection) or Freund’s
incomplete adjuvant (booster injections). A 200-l volume of the cell-
adjuvant suspension was injected into the rabbit once every 3 weeks, and
the animal was sacrificed and blood collected 10 days after the third
booster injection. The blood was allowed to clot for 1 h at37°C, followed
by an overnight incubation at4°C, after which the blood clot was sepa-
rated from the serum by centrifugation at 5,000 g for 10 min. The serum
was divided into aliquots and was stored at80°C prior to usage.
Immunofluorescence labeling of A. muciniphila cells adhering to
the Caco-2 and HT-29 cell lines. A. muciniphila cells were washed once
with PBS, adjusted to an OD600 of 0.25, and applied to Caco-2 or HT29
cell monolayers grown for 3 days on 8-well microscope slides. The micro-
scope slides were incubated for 1 h at 37°C either under a normal atmo-
sphere, in an incubator with 5% CO2, or in the anaerobic incubator. After
incubation, the slides were first washed 3 times with PBS and then fixed for
10 min with 4% paraformaldehyde (PFA) in PBS, followed by additional
washes with PBS. A 1:100 dilution of the rabbit antiserum raised against
whole cells of A. muciniphila was applied to the microscope slides (with
plain PBS for conjugate control), and the slides were incubated for 1 h at
room temperature. Next, the slides were washed 3 times with PBS and
were mounted for 1 h at room temperature with Alexa Fluor 594-conju-
gated goat anti-rabbit IgG (Invitrogen) and DAPI in PBS (each at 1 g
ml1). Unbound stains were removed by 3 washes with PBS, and the slides
were analyzed by a Leica DM4000 B fluorescence microscope with filter
cube A for DAPI and filter cube TX2 for Alexa Fluor 594.
Adhesion to extracellular matrix proteins. MaxiSorp 96-well micro-
titer plates were prepared for adhesion assays by coating the wells over-
night at 4°C with 2.5 pmol well1 bovine serum albumin (BSA; Sigma-
Aldrich), collagen I (Sigma-Aldrich), collagen IV (Sigma-Aldrich), fetuin
(Sigma-Aldrich), fibronectin (Calbiochem), or laminin (Sigma-Aldrich).
Coating was carried out in PBS. Next, the wells were washed twice with
PBS and were blocked for 1 h at room temperature with 0.5% (wt/vol)
BSA in PBS, followed by three additional washes with PBS. The [3H]thy-
midine-labeled bacteria were washed once with PBS, and the OD600 of the
bacterial suspension was adjusted to 0.25 before the cells were added to the
microtiter wells. A. muciniphila cells were allowed to bind to immobilized
ECM proteins for 1 h at 37°C, after which the wells were washed three
times with PBS. Bound bacteria were lysed by adding 1% SDS– 0.1 M
NaOH to the wells and incubating the plates for 1 h at 60°C. The radioac-
tivity was determined with a liquid scintillator, and the fraction of bound
cells was expressed as the percentage of the radioactivity of the cell sus-
pension initially added to the wells that was retained in the wells after
washing.
Binding to human intestinal epithelial cell lines andmucus. Thymi-
dine-labeled A. muciniphila and L. rhamnosus GG cells were collected by
centrifugation and were washed once with RPMI 1640 or McCoy 5A me-
dium without supplements, or with PBS, for the assay of adhesion to
Caco-2 cells, HT-29 cells, or mucus, respectively. After washing, the
OD600 of the bacterial suspension was adjusted to 0.25 in the respective
medium or PBS. Caco-2 and HT-29 cells were grown for 3, 8, and 21 days
and were washed twice with culture medium before the addition of bac-
teria. Mucus-coated wells were prepared as described for ECM protein-
coated wells above, by incubating the wells with 50 g well1 human
mucus in PBS, followed by blocking with 0.5% BSA in PBS. The OD-
adjusted bacterial suspensions were added to the wells, which were then
incubated for 1 h at 37°C. The epithelial cells with bacteria were incubated
in the CO2 incubator. The wells were then washed three times with PBS,
and the bound bacteria were lysed and quantified as described above.
TER assay. Caco-2 cells (5  104/insert) were seeded in Millicell cell
culture inserts (pore size, 3 m; Millipore) and were grown for 8 days.
Bacterial cells were washed once with RPMI 1640 and were applied to the
inserts at an OD600 of 0.25 in RPMI 1640. Transepithelial electrical resis-
tance (TER) was determined with a Millicell ERS-2 TER meter (Millipore)
from cell cultures at 0 h, 24 h, and 48 h after the addition of bacterial cells.
Induction of IL-8 production in HT-29 cells. Ten thousand HT-29
cells per well were seeded onto 96-well microplates and were grown for 8
days in McCoy 5A medium with supplements. A. muciniphila, B. fragilis,
and E. coli cells were washed, and the OD600 was adjusted as described
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above in McCoy 5A medium. Bacteria were serially diluted in McCoy 5A
medium to 1:100, 1:1,000, and 1:10,000, which corresponded to 106, 105,
and 104 cells/ml, respectively. Two hundred microliters of each dilution
was added to HT-29 wells, and the cocultures were kept for 3 h at 37°C in
the CO2 incubator. For positive-control wells, 1 ng/ml of E. coli lipopoly-
saccharide (LPS; Sigma) was added to the culture medium, whereas plain
culture medium served as a negative control. After the 3 h of incubation,
the concentration of interleukin-8 (IL-8) in the culture supernatant was
measured with an OptEIA Human IL-8 ELISA set (BD Biosciences) ac-
cording to the manufacturer’s instructions.
Western blotting. A. muciniphila and E. coli cells were suspended in
loading buffer and were boiled for 5 min, followed by SDS-PAGE under
denaturing conditions on 4-to-15% gradient gels (Bio-Rad) and electro-
blotting onto polyvinylidene difluoride (PVDF) Immobilon P mem-
branes (Millipore). The membrane was first probed with a rabbit poly-
clonal antiserum against E. coli LPS (Bioss Inc.) and then incubated with a
horseradish peroxidase (HRP)-conjugated goat anti-rabbit IgG secondary
antibody (Bio-Rad) diluted 1:100,000. The blot was visualized using the
Amersham ECL Advance Western blotting detection kit (GE Healthcare
Bio-Sciences) according to the manufacturer’s instructions.
Preparation of immunogold-labeled thin sections and TEM. Lowic-
ryl HM20-embedded thin sections of A. muciniphila and E. coli cells were
prepared as described previously (17). Briefly, the cells were washed once
with phosphate buffer (0.1 M Na phosphate, pH 7.4) and were fixed for 4
h at room temperature in 4% PFA and 0.1% glutaraldehyde in phosphate
buffer. After fixation, the cells were collected and were resuspended in 2%
PFA in phosphate buffer, followed by embedding in Lowicryl HM20 resin
by freeze substitution. Ultrathin sections cut from polymerized Lowicryl
were placed on nickel grids and were blocked for 20 min in 1% BSA, 0.5%
fish skin gelatinase (FSG), and 1% FCS in phosphate buffer, after which
they were incubated for 1 h with antisera against E. coli LPS (Bioss Inc.) or
lipid A (Glycobiotech) in 2% BSA, 0.1% Tween 20, and 0.1% FSG in
phosphate buffer. The grids were then washed several times with pAg
(colloidal gold particles conjugated to protein A) buffer (0.2% BSA,
0.01% Tween 20, and 0.01% FSG in phosphate buffer) and were incubated
for 20 min with 10-nm pAg diluted 1:55 in pAg buffer. The grids were
washed several times with phosphate buffer and were washed extensively
with water. Prior to analysis by transmission electron microscopy (TEM),
the grids were poststained with uranyl acetate and lead citrate. The grids
were analyzed with a JEOL 1400 transmission electron microscope.
Statistical analysis. Three to five parallel wells (i.e., technical repli-
cates) were used in each experiment, and all experiments were repeated
two to six times. A pairwise Student t test was used to determine signifi-
cant differences (P 0.05) between the control and samples or between
two different experimental conditions. In the figures, mean values stan-
dard deviations for technical replicates (parallel wells) of representative
experiments are shown.
RESULTS
Oxygen sensitivity of A. muciniphila. In order to assess the via-
bility of A.muciniphila under the experimental conditions used in
our in vitro assays, we first analyzed the effects of different incu-
bation atmospheres on A. muciniphila cells by using live-dead
fluorescence staining. Importantly, A. muciniphila cells that were
kept for 1 h under oxic, 5% CO2, or anoxic conditions showed
similar staining patterns, and more than 90% of the cells stained
live, i.e., stained only with DAPI (Fig. 1; see also Fig. S1 in the
supplemental material), indicating that A. muciniphila can toler-
ate oxygen. Since A. muciniphila cells were not severely compro-
mised by the use of oxic incubation conditions, the different
incubation conditions were also compared in an adhesion exper-
iment. We incubated the bacterium with Caco-2 or HT29 cell
monolayers under an anaerobic or 5% CO2 atmosphere, followed
by immunofluorescence microscopy with antibodies raised
against whole A.muciniphila cells. We could not see any difference
between the levels of binding under the two different atmospheres
(Fig. 2). Similarly, binding to ECM proteins was not affected by
the presence of oxygen (data not shown). On the basis of these
results, and for practical reasons, we performed all subsequent
experiments with enterocytes under a 5% CO2 atmosphere and
other experiments under a normal atmosphere.
Adhesion ofA. muciniphila to extracellular matrix proteins.
The adhesion of A. muciniphila to human ECM proteins (colla-
gens I and IV, fibronectin, and laminin) was studied by determin-
ing the binding of radiolabeled A. muciniphila cells to immobi-
lized ligands. Bovine serum albumin was used as a negative
control, and fetuin was used as a representative highly glycosylated
protein. In comparison with background-level binding to BSA, A.
muciniphila bound significantly only to laminin (Fig. 3). Binding
FIG 1 Live-dead fluorescence staining of A. muciniphila cells exposed to dif-
ferent atmospheres. A. muciniphila cells were incubated for 1 h under an aer-
obic, 5% CO2, or anaerobic atmosphere. Relative fluorescence units (RFU)
were measured after staining of the cells with DAPI or propidium iodide (PI),
which stains only dead or seriously impaired cells. Background fluorescence
from nonstained cells has been subtracted from the RFU values obtained. The
results shown are means and standard deviations for four parallel samples. FIG 2 Adhesion of A. muciniphila cells to the Caco-2 and HT29 human epi-
thelial cell lines. Adhesion was carried out under an anaerobic or 5% CO2
atmosphere and was assessed by immunofluorescence microscopy. Enterocyte
nuclei were strained with DAPI (blue), and A. muciniphila cells were stained
with a polyclonal rabbit antiserum raised against whole A. muciniphila cells
and a secondary antibody conjugated with Alexa Fluor 594 (red).
Epithelial Interactions of Akkermansia muciniphila
June 2015 Volume 81 Number 11 aem.asm.org 3657Applied and Environmental Microbiology
 o
n
 M
arch 20, 2018 by TERKKO
 NATIO
NAL LIBRARY O
F HEALTH SCIENCES
http://aem
.asm
.org/
D
ow
nloaded from
 
to collagens I and IV, fibronectin, and fetuin was at the back-
ground level.
Binding tohuman intestinalmucusandepithelial cells.Next,
we studied the adhesion of A. muciniphila to the Caco-2 and
HT-29 cell lines and to mucus. L. rhamnosus GG was included in
the experiments as a positive-control strain, since its ability to
bind to human mucus and enterocytes has been well established
(18, 19). Surprisingly, A. muciniphila did not bind human colonic
mucus—the level of adhesion was less than 1%, which can be
considered nonspecific, background-level binding—while ap-
proximately 20% of the added L. rhamnosus GG cells were found
to be mucus bound (Fig. 4). In contrast, the level of adhesion of A.
muciniphila to human enterocytes was comparable to that of L.
rhamnosus GG (Fig. 4). Next, the binding of A. muciniphila to
enterocytes grown for different periods (3 days, 8 days, and 21
days) was studied. The differentiation of Caco-2 cells starts within
3 to 4 days after confluence (20, 21), and we used undifferentiated
cells with confluent growth (3 days) and cells at two differentia-
tion stages, grown for 8 and 21 days (i.e., 5 and 18 days after
confluence, respectively). The HT-29 cell line does not differenti-
ate, but we used the same growth times for comparison. In gen-
eral, A. muciniphila adhered equally well to both enterocyte lines
at all growth states, except for 3-day-old HT-29 cells, to which it
adhered at a lower level (Fig. 5).
Effect of A. muciniphila on Caco-2 monolayer integrity. The
impact of A.muciniphila on the integrity of the epithelial cell layer
was assessed by determining the development of the transepithe-
lial electrical resistance (TER) of a Caco-2 monolayer, which was
cocultured with A. muciniphila. TER is a measure of ion passage
across tissue or a cultured enterocyte monolayer (22), and there-
fore, the epithelial barrier function is commonly assessed by de-
termining the TER. E. coli was chosen as a representative bacte-
rium that has adverse effects on epithelial cell monolayer integrity
(23), and B. fragilis was included in the assay for comparison. The
bacteria were administered to 8-day-old Caco-2 cells, and TER
was measured at 24-h intervals. After 24 h of cocultivation, both A.
muciniphila and B. fragilis had significantly increased the TER,
whereas the TER of Caco-2 cocultures with E. coli had decreased
significantly, relative to that of Caco-2 cultures without added
bacteria (Fig. 6). At this time point, the OD600 values for A. muci-
niphila and B. fragilis cell suspensions showed essentially no
growth, whereas the number of E. coli cells had increased slightly
FIG 3 Binding of A. muciniphila to ECM proteins. Metabolically labeled A.
muciniphila cells were allowed to bind to different human extracellular matrix
proteins. The results shown are means and standard deviations for five parallel
wells. The asterisk indicates a level of binding significantly different (P 0.05)
from background binding (to BSA).
FIG 4 Adherence of A. muciniphila to the Caco-2 and HT-29 cell lines and to
human intestinal mucus. A. muciniphila and L. rhamnosus GG (positive-con-
trol strain) cells were allowed to bind to human enterocytes or immobilized
intestinal mucus. Means and standard deviations for five parallel wells are
shown.
FIG 5 Adherence of A. muciniphila to Caco-2 and HT-29 cells at different
growth stages. Levels of binding to mucus are shown for comparison. Data are
means and standard deviations for five parallel wells. The asterisk indicates a
significant difference (P  0.05) in adhesion to the different cell lines at the
same growth stage.
FIG 6 Impact of A.muciniphila, B. fragilis, or E. coli on the development of the
TER of a Caco-2 monolayer. Means and standard deviations for three parallel
wells are shown. Asterisks indicate TER values significantly different (P 
0.05) from that of the control (growth medium without bacteria).
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(from an OD600 of 0.25 to an OD600 of 0.38) (see Fig. S2 in the
supplemental material). At 24 h, the positive impact on cell mono-
layer integrity was more profound with B. fragilis than with A.
muciniphila, whereas E. coli with an essentially similar cellular
density clearly affected TER development negatively. At 48 h after
the establishment of cocultures, the TER of a Caco-2 cell layer
cultured with E. coli had decreased even more, while the TER of
Caco-2 cocultures with A. muciniphila had risen to the same level
as that of B. fragilis cocultures (Fig. 6). The cell densities of B.
fragilis and A. muciniphila did not change during the 48 h of in-
cubation in the Caco-2 medium, and the bacterial cells did not
seem to be severely compromised either, as evidenced by the live-
dead staining results (see Fig. S2). The E. coli cell suspension, on
the other hand, showed an increase in the OD600 from 0.25 to 0.5,
i.e., one cell division occurred during 48 h, which is likely to have
affected the further decrease of TER in E. coli cocultures.
Effect of A. muciniphila on interleukin-8 production in
HT-29 cells. The proinflammatory capacity of A. muciniphila was
assayed by measuring its effect on IL-8 production by HT-29 cells.
The HT-29 cells were incubated with different numbers of A. mu-
ciniphila, B. fragilis, or E. coli cells, while pure culture medium
served as a background control and pure LPS as a positive control.
E. coli was used in this assay because it has been shown to trigger
IL-8 secretion in vitro, whereas B. fragilis was included because its
LPS has been demonstrated to differ markedly from that of E. coli
(24, 25). As expected, E. coli elicited a strong, dose-dependent IL-8
response in HT-29 epithelial cells, whereas no IL-8 production
was induced when the cells were exposed to B. fragilis (Fig. 7).
While lower doses of A. muciniphila failed to show any effect on
IL-8 production, an increase in IL-8 release was observed with the
largest number of A. muciniphila cells (1:100 dilution; 106 bacte-
ria/ml1) (Fig. 7). However, a similar level of IL-8 release was
achieved with only 104 E. coli cells ml1, suggesting that the pro-
inflammatory effect of A. muciniphila on enterocytes is minor
compared to that of E. coli (Fig. 7).
Presence of LPS in A. muciniphila cells. Since A. muciniphila
showed only minor proinflammatory activity on HT-29 cells, we
investigated whether A. muciniphila produces LPS and, if so,
whether A.muciniphila LPS is distinct from that of E. coli. For that
purpose, we first analyzed whole-cell preparations of A. mucini-
phila and E. coli by Western blotting. The antiserum against E. coli
LPS reacted with E. coli, whereas only a weak signal, if any, could
be detected with an A. muciniphila lysate (Fig. 8A). Next, we ana-
lyzed thin sections of A. muciniphila cells immunolabeled with
antibodies against lipid A from E. coli by TEM. As shown in Fig.
8B, anti-lipid A antibodies reacted with the envelopes of both A.
muciniphila and E. coli cells.
FIG 7 Induction of IL-8 production in HT-29 cells by A. muciniphila, B.
fragilis, and E. coli. Means and standard deviations for three parallel wells are
shown. Asterisks indicate IL-8 production levels significantly (P 0.05) above
the background level (growth medium without bacteria or LPS). LPS (1 ng
ml1) from E. coli was included as a positive control.
FIG 8 Analysis of LPS and lipid A contents of A. muciniphila. (A) Western blotting of whole-cell lysates of A. muciniphila (lane 2) and E. coli (positive control)
(lane 3) using an antiserum against E. coli LPS. Lane 1, molecular mass standard. (B) Electron micrographs of thin-sectioned and immunostained A.muciniphila
and E. coli bacteria. The bacteria were immunostained using an antiserum against E. coli lipid A and 10-nm colloidal gold particles conjugated to protein A (pAg).
Arrows indicate 10-nm gold particles. Bars, 500 nm.
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DISCUSSION
Akkermansia muciniphila is an anaerobic bacterium isolated from
human feces. Our results show that A. muciniphila is an aerotol-
erant anaerobic bacterium rather than a strict anaerobe, in con-
trast to many other members of the human intestinal microbiota.
Our preliminary plate count data indicate that 80% of A. mucini-
phila cells exposed to atmospheric oxygen levels for 1 h survive
(data not shown). Currently, we cultivate A. muciniphila success-
fully by inoculating the cultures in a laminar hood under a normal
oxic atmosphere and incubating them in an anaerobic jar with a
chemically created oxygen-free CO2 atmosphere (Anaerocult;
Merck) instead of the anaerobic cabinet. Thus, there is no need to
treat the organism as a highly oxygen sensitive anaerobe.
The ability to bind to the epithelial surface is thought to en-
hance the colonization of the digestive tract by a bacterial strain.
The bacterium might, in principle, adhere to intact epithelium
through binding to enterocytes, different components of the mu-
cus gel, or other bacteria inhabiting the epithelial surface. In the
event of disruption of the mucosal surface, epithelial binding
could also be achieved by binding to various components of the
extracellular matrix. In this study, we analyzed the adhesion of
the human commensal A. muciniphila to various components of
the human GI tract epithelium. Remarkably, A. muciniphila
showed no binding to human colonic mucin, even though it lives
in an intimate relationship with the intestinal mucosa and also
utilizes it as a nutrient. We have shown previously, by using the
same mucus binding assay, that the human intestinal isolates L.
rhamnosus GG and Bifidobacterium bifidum DSM20456 and
MIMBb75 bind strongly to human colonic mucus (15, 18). How-
ever, L. rhamnosus and B. bifidum are nonmucolytic bacteria,
whereas A. muciniphila is a mucin-degrading bacterium. There-
fore, the result may reflect the mucinolytic nature of A. mucini-
phila; i.e., we cannot presently rule out the possibility that A. mu-
ciniphila cells might be detached from the immobilized mucus as a
result of their mucin-degrading enzymatic activity. The binding
assay incubations were carried out under aerobic conditions,
which did not severely damage A. muciniphila cells. Presumably,
the main mucolytic enzymes of A. muciniphila may stay active
under these conditions. On the other hand, since A. muciniphila
adhered to cultured enterocytes, it is possible that epithelial en-
terocytes could serve as bona fide intestinal docking sites for ad-
herent A. muciniphila cells. Therefore, in future work, we shall
investigate whether this counterintuitive observation, i.e., the lack
of mucus-binding ability of A. muciniphila, is due to the experi-
mental conditions used in the mucus binding assay. Nevertheless,
since A. muciniphila is found to reside on the colonic mucus, the
question of how this organism manages to stably occupy this con-
stantly renewing ecological niche remains to be answered.
In contrast to its lack of binding to mucus, A. muciniphila
showed firm binding to the cultured colonic epithelial cell lines
Caco-2 and HT-29. Although the highest A. muciniphila cell
counts are found in the colon, the small intestine is also colonized
by substantial numbers of A. muciniphila cells (5). In the small
intestine, the mucus layer is permeable to bacteria, allowing direct
contacts between bacteria and enterocyte surfaces (14). Therefore,
A. muciniphila may use direct binding to enterocytes as a coloni-
zation strategy in the small intestine. The epithelial cell layer in the
GI tract is renewed approximately once every 4 to 5 days in a
process in which undifferentiated enterocyte progenitors derived
from stem cells move from the intestinal crypts toward the tips of
villi (26). The immature enterocytes differentiate en route to the
villus tip, where they replace the old enterocytes, which are shed
into the intestinal lumen (27). Interestingly, the enterocyte bind-
ing strength of A.muciniphila was independent of the growth state
of Caco-2 cells, indicating that the host-binding site utilized by the
bacterium is expressed on the cell surface irrespective of the state
of cell differentiation. It is well known that the expression of sur-
face molecules is influenced by the differentiation stage in epithe-
lial cells (28, 29) and that bacterial adhesion to enterocytes is af-
fected by the profile of surface-associated molecules in the
enterocytes (30). Based on our findings, it seems possible that A.
muciniphila is able to bind enterocytes at various differentiation
stages in vivo.
The intestinal epithelium is subject to mechanical stress during
the digestion of food, and as a result, the epithelium frequently
suffers minor breaks in its integrity (26, 31). These wounds expose
the subepithelium, along with its ECM network, to the intestinal
lumen, allowing intestinal bacteria temporary access to the ECM
components. ECM components, being natural constituents of the
network of macromolecules, are also found in the mucus (32).
Since we found that A. muciniphila binds laminin and undifferen-
tiated Caco-2 cells, it is tempting to speculate that A. muciniphila
might participate in the competitive exclusion of pathobionts
from the sites of injury and fortify the de novo-established entero-
cyte monolayer after an epithelial insult. In favor of this view is our
observation that A. muciniphila significantly increased the TER in
coculture with Caco-2 cells, whereas E. coli decreased the TER
under the same culture conditions. The strengthening of epithelial
barrier function could also explain several in vivo observations
linking A. muciniphila not only to gut health but also to systemic
health. The impaired integrity of intestinal epithelium leads to the
accumulation of LPS from Gram-negative gut inhabitants in the
serum, resulting in metabolic endotoxemia with concomitant in-
flammation (33, 34). Since diabetes and obesity have been linked
with increased gut permeability and low-grade inflammation (35,
36), LPS-induced endotoxemia has been suggested as one of the
causative agents of obesity and its related metabolic disorders (33,
37, 38). Our in vitro observation that A. muciniphila fortifies epi-
thelial barrier function could provide a working hypothesis for
attempts to rationalize the in vivo findings connecting decreased
fecal A. muciniphila levels with diabetes and obesity (8, 9) and
could reveal one possible mechanism behind the protective effect
of the bacterium against high-fat-diet-induced LPS endotoxemia
in obese mice (13).
IL-8 is a mediator of inflammation, causing immune cells to
migrate to the site of infection and inducing phagocytosis, and it
plays an important role in host defense against pathogens (39).
However, the stimulation of massive IL-8 production in a healthy,
intact epithelium would lead to unnecessary inflammation and
disturbance of mucosal homeostasis. We found that A. mucini-
phila induced IL-8 production in enterocytes at cell concentra-
tions 100-fold higher than those for E. coli. Thus, A. muciniphila
does not seem to be able to provoke a strong inflammatory cascade
in the epithelium. The finding is in line with the reported in vivo
investigations linking A. muciniphila with noninflamed rather
than inflamed mucosa (5–7). On the other hand, the low-level
proinflammatory stimulation of enterocytes by A. muciniphila
may keep the mucosa-associated immune system alerted at an
appropriate level. The A. muciniphila genome sequence contains
Reunanen et al.
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the genetic elements necessary for the production of LPS (4). In
contrast to E. coli or its LPS, A. muciniphila did not induce strong
IL-8 release from HT-29 cells. Thus, A. muciniphila LPS does not
seem to be a powerful activator of host Toll-like receptor 4 (TLR4)
and likely differs structurally from E. coli LPS. Recently, B. fragilis
LPS has been shown to signal through TLR2, not through the
well-recognized LPS receptor TLR4 (24). B. fragilis LPS is struc-
turally atypical, differing from classical LPS by the length of the
O-antigen polysaccharide and the phosphorylation of lipid A di-
glucosamine (24, 25). We attempted to detect LPS in A. mucini-
phila by Western blotting using polyclonal antisera raised against
E. coli LPS. Since this approach was unsuccessful with A. mucini-
phila, we performed immunoelectron microscopic analysis of
thin-sectioned A. muciniphila and E. coli cells. By this method, we
were able to immunostain thin sections of A. muciniphila cells
with anti-lipid A antiserum, indicating that the bacterium pro-
duces lipid A and therefore, most likely, also LPS. We propose that
there are structural and antigenic disparities between the LPS
polysaccharide structures of A. muciniphila and E. coli, as evi-
denced by the reactivity of anti-lipid A antibodies but the nonre-
activity of antibodies raised against E. coli LPS. These findings
warrant future exploration of the precise immunosignaling prop-
erties of A. muciniphila, including the identification of the host
side receptors involved therein.
In this study, by using in vitro methods, we have revealed sev-
eral interactions of A. muciniphila with intestinal epithelium. The
somewhat unexpected binding preference of A. muciniphila for
epithelial cells and laminin over colonic mucus raises questions
about the possible physical niches utilized by this organism to
stably colonize the human GI tract. Our findings that A. mucini-
phila is capable of adhering to both nondifferentiated and mature
enterocytes and that upon this interaction, the bacterium does not
provoke a proinflammatory reaction but instead elicits the
strengthening of epithelial integrity open multiple exciting paths
for further study of the putative beneficial interactions of A. mu-
ciniphila with the host.
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